Breast cancer is one of the most common forms of cancer affecting women and, like so many other cancers, the prospects for the patient depend heavily on early diagnosis and treatment. Radiotherapy treatment can play a major role, but for certain risk groups it may not be needed following a mastectomy. This article explains what has […]
Radiotherapy has been around since the turn of the 20th century, but as our understanding of radiation has improved and the technology for deploying it has developed, so has the capacity to bring about better results for patients. If you require radiotherapy, there are different kinds you may have depending on your condition. For some, the […]
Investment platform Healthcare Business International (HBI) has published a news story on the new alliance between private oncology groups Amethyst Healthcare (with centres in seven countries across Europe) and Stingray (with a major presence in both France and Germany). The integration was made possible thanks to the acquisition of Stingray by private equity firm Fremman […]
Amethyst Healthcare has announced a strategic alliance with European oncology network Stingray Healthcare, based in Lausanne, Switzerland, a move that will see the biggest independent cancer care platform created. The new partnership will see patient access expanded to high-quality cancer care across Europe, with over 30 treatment centres across eight countries in operation and approximately […]
The beginning of cancer treatment can feel like a whirlwind at times; following a positive diagnosis, a lot of different stages of treatment progress very quickly to ensure you receive the highest quality radiotherapy treatment as soon as it is appropriate to do so. This includes the initial tests, referrals, the specialist tests which confirm the […]
Amethyst Healthcare today announced the creation of Europe’s largest independent cancer care platform following its combination with Stingray Healthcare, a leading European oncology network headquartered in Lausanne, Switzerland. The transaction follows Fremman Capital’s acquisition of Stingray from Jacobs Capital. The new group brings together two highly complementary organisations united by a shared mission to expand […]
Testicular cancer is one of those conditions that is, by its very nature, often made harder to treat by later diagnosis. The general reluctance of men to seek medical advice is well documented. However, it is a form of cancer that is nearly always treated successfully, leaving the patient surviving and cancer-free. Every so often, […]
Prostate cancer is one of the most common forms of cancer affecting men. The most recent EU-wide figures (for 2020) showed it accounted for 23 per cent of cancer diagnoses in men, while data for the UK between 2017 and 2019 put the figure at 28 per cent. There are some significant demographic variations. For instance, the […]
Amethyst Healthcare, one of the leading providers of advanced radiotherapy and integrated cancer care in Europe, has announced that it has now established a firm presence in Portugal, following the acquisition of private Portuguese radiotherapy provider Júlio Teixeira. This strategic move will ensure that people in Portugal are better able to enjoy even greater access […]
The value of radiotherapy treatment for cancer has grown exponentially over the years. When it was first used in the early 20th century, its effects were merely palliative and while that is still a use for it today, there is now so much more that can be achieved, with some patients making a full recovery and being able to […]
